The George Institute For Global Health
United Kingdom


Found 5059 results
Filters: Type is Journal Article  [Clear All Filters]
Toyama T, Neuen B, Jun M, et al. Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and meta-analysis. Diabetes Obes Metab. 2019. doi:10.1111/dom.13648.
Anderson C, Huang Y, Lindley R, et al. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial. Lancet. 2019. doi:10.1016/S0140-6736(19)30038-8.
Bailie J, Laycock A, Matthews V, Peiris D, Bailie R. Emerging evidence of the value of health assessments for Aboriginal and Torres Strait Islander people in the primary healthcare setting. Australian Journal of Primary Health. 2019. doi:10.1071/PY18088.
Berkelmans G, Gudbjörnsdottir S, Visseren F, et al. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mel. Eur Heart J. 2019. doi:10.1093/eurheartj/ehy839.
Maulik P, Devarapalli S, Kallakuri S, Tripathi A, Koschorke M, Thornicroft G. Longitudinal assessment of an anti-stigma campaign related to common mental disorders in rural India. British Journal of Psychiatry. 2019;214:90 - 95. doi:10.1192/bjp.2018.190.
Lartey S, Magnussen C, Si L, et al. The role of intergenerational educational mobility and household wealth in adult obesity: Evidence from wave 2 of the world health organization's study on global ageing and adult health. PLoS ONE. 2019;14. doi:10.1371/journal.pone.0208491.
Wang Z, Zhou X, Gao Y, Chen M, Palmer A, Si L. Did expansion of health insurance coverage reduce horizontal inequity in healthcare finance? A decomposition analysis for China. BMJ Open. 2019;9. doi:10.1136/bmjopen-2018-025184.
Jin K, Khonsari S, Gallagher R, et al. Telehealth interventions for the secondary prevention of coronary heart disease: A systematic review and meta-analysis. European Journal of Cardiovascular Nursing. 2019. doi:10.1177/1474515119826510.
McGuire D, Alexander J, Johansen O, et al. Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA. Circulation. 2019;139:351 - 361. doi:10.1161/CIRCULATIONAHA.118.038352.
Heerspink H, Greene T, Tighiouart H, et al. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials. The Lancet Diabetes and Endocrinology. 2019;7:128 - 139. doi:10.1016/S2213-8587(18)30314-0.
McKenzie B, Trieu K, Grimes C, Reimers J, Webster J. Understanding barriers and enablers to state action on salt: Analysis of stakeholder perceptions of the vichealth salt reduction partnership. Nutrients. 2019;11. doi:10.3390/nu11010184.
Figtree G, Rådholm K, Neal B. Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)". Circulation. 2019;139:418 - 419. doi:10.1161/CIRCULATIONAHA.118.038477.
Zhou Z, Lindley R, Rådholm K, et al. Canagliflozin and Stroke in Type 2 Diabetes Mellitus. Stroke. 2019;50:396 - 404. doi:10.1161/STROKEAHA.118.023009.
Andrew N, Middleton S, Grimley R, et al. Hospital organizational context and delivery of evidence-based stroke care: A cross-sectional study. Implementation Science. 2019;14. doi:10.1186/s13012-018-0849-z.
Armitage J, Baigent C, Barnes E, et al. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. The Lancet. 2019;393:407 - 415. doi:10.1016/S0140-6736(18)31942-1.
Smyth B, Krishnan A, Gallagher M, et al. Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol. BMJ Open. 2019;9. doi:10.1136/bmjopen-2018-023736.
Ramachandran R, Nayak S, Anakutti H, et al. Is Postpartum Renal Cortical Necrosis in Developing Countries Due to Atypical Hemolytic Uremic Syndrome?. Kidney International Reports. 2019. doi:10.1016/j.ekir.2018.11.012.
Dennis M, Mead G, Forbes J, et al. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. The Lancet. 2019;393:265 - 274. doi:10.1016/S0140-6736(18)32823-X.
Carcel C, Farnbach S, Essue B, et al. Returning to Unpaid Work after Stroke: The Psychosocial Outcomes in Stroke Cohort Study. Cerebrovascular Diseases. 2019:1 - 7. doi:10.1159/000496399.
Coresh J, Heerspink H, Sang Y, et al. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies. The Lancet Diabetes and Endocrinology. 2019;7:115 - 127. doi:10.1016/S2213-8587(18)30313-9.
Koskinen J, Juonala M, Dwyer T, et al. Utility of Different Blood Pressure Measurement Components in Childhood to Predict Adult Carotid Intima-Media Thickness. Hypertension (Dallas, Tex. : 1979). 2019;73:335 - 341. doi:10.1161/HYPERTENSIONAHA.118.12225.
Ou Q, Chen B, Loffler K, et al. The Effects of Long-term CPAP on Weight Change in Patients With Comorbid OSA and Cardiovascular Disease: Data From the SAVE Trial. Chest. 2019. doi:10.1016/j.chest.2018.08.1082.
Carcel C, Farnbach S, Essue B, et al. Returning to Unpaid Work after Stroke: The Psychosocial Outcomes in Stroke Cohort Study. Cerebrovasc Dis. 2019;47:1 - 7. doi:10.1159/000496399.
Farrand C, MacGregor G, Campbell N, Webster J. Potential use of salt substitutes to reduce blood pressure. J Clin Hypertens (Greenwich). 2019. doi:10.1111/jch.13482.
McKenzie B, Trieu K, Grimes C, Reimers J, Webster J. Understanding Barriers and Enablers to State Action on Salt: Analysis of Stakeholder Perceptions of the VicHealth Salt Reduction Partnership. Nutrients. 2019;11. doi:10.3390/nu11010184.